- Home
- AEYE vs VALN Comparison
AEYE vs VALN Comparison
Compare AEYE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEYE
- VALN
- Stock Information
- Founded
- AEYE 2005
- VALN 2012
- Country
- AEYE United States
- VALN France
- Employees
- AEYE N/A
- VALN N/A
- Industry
- AEYE Computer Software: Prepackaged Software
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AEYE Technology
- VALN Health Care
- Exchange
- AEYE Nasdaq
- VALN Nasdaq
- Market Cap
- AEYE 278.0M
- VALN 332.0M
- IPO Year
- AEYE N/A
- VALN 2021
- Fundamental
- Price
- AEYE $18.22
- VALN $3.89
- Analyst Decision
- AEYE Strong Buy
- VALN Strong Buy
- Analyst Count
- AEYE 4
- VALN 2
- Target Price
- AEYE $30.13
- VALN $18.50
- AVG Volume (30 Days)
- AEYE 335.8K
- VALN 30.5K
- Earning Date
- AEYE 11-07-2024
- VALN 11-07-2024
- Dividend Yield
- AEYE N/A
- VALN N/A
- EPS Growth
- AEYE N/A
- VALN N/A
- EPS
- AEYE N/A
- VALN N/A
- Revenue
- AEYE $33,348,000.00
- VALN $176,817,979.00
- Revenue This Year
- AEYE $14.64
- VALN $24.30
- Revenue Next Year
- AEYE $21.65
- VALN $16.05
- P/E Ratio
- AEYE N/A
- VALN N/A
- Revenue Growth
- AEYE 6.94
- VALN N/A
- 52 Week Low
- AEYE $4.01
- VALN $3.65
- 52 Week High
- AEYE $34.85
- VALN $10.76
- Technical
- Relative Strength Index (RSI)
- AEYE 32.79
- VALN 37.11
- Support Level
- AEYE $16.61
- VALN $3.62
- Resistance Level
- AEYE $22.62
- VALN $4.09
- Average True Range (ATR)
- AEYE 1.73
- VALN 0.20
- MACD
- AEYE -0.91
- VALN 0.03
- Stochastic Oscillator
- AEYE 4.37
- VALN 39.44
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.